Patents by Inventor Lynn Markowitz

Lynn Markowitz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PPHARMACEUTICAL FORMULATIONS AND THERAPEUTIC USES OF MULTI-SPECIFIC BINDING PROTEINS THAT BIND EGFR, NKG2D, AND CD16
    Publication number: 20230250176
    Abstract: Described herein are pharmaceutical formulations comprising multi-specific binding proteins that bind to NKG2D, CD16, and epidermal growth factor receptor (EGFR); and therapeutic uses of the multi-specific binding proteins and pharmaceutical formulations thereof for treating a disease, for example, cancer, in a patient in need thereof.
    Type: Application
    Filed: February 9, 2023
    Publication date: August 10, 2023
    Inventors: Ann F. Cheung, Jean-Marie Cuillerot, Mark DeRose, Stacey V. Drabic, Asya Grinberg, Zong Sean Juo, Aaron Levin, Katia Liharska, Lynn Markowitz, Christopher Ryan Morgan, Avni Shah, Michael Shifrin, Nicolai Wagtmann
  • Modified glycoproteins
    Patent number: 10377832
    Abstract: Modified glycoproteins, and methods of making and using such modified glycoproteins, are described.
    Type: Grant
    Filed: April 25, 2017
    Date of Patent: August 13, 2019
    Assignee: Momenta Pharmaceuticals, Inc.
    Inventors: Nathaniel Washburn, James Meador, III, Carlos J. Bosques, Dorota A. Bulik, Naveen Bhatnagar, Julia Brown, Lynn Markowitz, Sathya Prabbhakar
  • MODIFIED GLYCOPROTEINS
    Publication number: 20170349662
    Abstract: Modified glycoproteins, and methods of making and using such modified glycoproteins, are described.
    Type: Application
    Filed: April 25, 2017
    Publication date: December 7, 2017
    Inventors: Nathaniel Washburn, James Meador, III, Carlos J. Bosques, Dorota A. Bulik, Naveen Bhatnagar, Julia Brown, Lynn Markowitz, Sathya Prabbhakar
  • Modified glycoproteins
    Patent number: 9663581
    Abstract: Modified glycoproteins, and methods of making and using such modified glycoproteins, are described.
    Type: Grant
    Filed: April 24, 2013
    Date of Patent: May 30, 2017
    Assignee: Momenta Pharmaceuticals, Inc.
    Inventors: Nathaniel Washburn, James Meador, III, Carlos J. Bosques, Dorota A. Bulik, Naveen Bhatnagar, Julia Brown, Lynn Markowitz, Sathya Prabbhakar
  • MODIFIED GLYCOPROTEINS
    Publication number: 20150299331
    Abstract: Modified glycoproteins, and methods of making and using such modified glycoproteins, are described.
    Type: Application
    Filed: April 24, 2013
    Publication date: October 22, 2015
    Inventors: Nathaniel Washburn, James Meador, III, Carlos J. Bosques, Dorota A. Bulik, Naveen Bhatnagar, Julia Brown, Lynn Markowitz, Sathya Prabbhakar
  • GLYCOPROTEIN PREPARATIONS
    Publication number: 20150252108
    Abstract: Preparations of glycoproteins, e.g., therapeutic preparations of glycoproteins, having altered levels of affinity for Fc? receptors relative to reference glycoprotein preparations, and methods of making and methods of using such preparations, are described.
    Type: Application
    Filed: September 25, 2013
    Publication date: September 10, 2015
    Applicant: Momenta Pharmaceuticals, Inc.
    Inventors: Nathaniel J. Washburn, Jonathan C. Lansing, Carlos J. Bosques, Naveen Bhatnagar, Dorota A. Bulik, Lynn Markowitz, Sandra Sipsey